Compare · ASTC vs AVTR
ASTC vs AVTR
Side-by-side comparison of Astrotech Corporation (DE) (ASTC) and Avantor Inc. (AVTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ASTC and AVTR operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- AVTR is the larger of the two at $10.88B, about 1041.7x ASTC ($10.4M).
- Over the past year, ASTC is up 18.1% and AVTR is up 8.2% - ASTC leads by 10.0 points.
- ASTC has been more active in the news (6 items in the past 4 weeks vs 1 for AVTR).
- AVTR has more recent analyst coverage (25 ratings vs 0 for ASTC).
- Company
- Astrotech Corporation (DE)
- Avantor Inc.
- Price
- $4.79-7.09%
- $16.41+1.96%
- Market cap
- $10.4M
- $10.88B
- 1M return
- -23.87%
- +3.53%
- 1Y return
- +18.15%
- +8.17%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2019
- News (4w)
- 6
- 1
- Recent ratings
- 0
- 25
Astrotech Corporation (DE)
Astrotech Corporation operates as a science and technology development and commercialization company worldwide. It operates through three segments, Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). The ATI segment owns and licenses the AMS Technology, the platform mass spectrometry technology. The 1st Detect segment manufactures explosives and narcotics trace detectors for use at airports, secured facilities, and borders. This segment provides TRACER 1000, a mass spectrometer based explosives trace detector to replace the explosives trace detectors used at airports, cargo and secured facilities, and borders. The AgLAB segment develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. It also develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. Astrotech Corporation was incorporated in 1984 is based in Austin, Texas.
Avantor Inc.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Latest ASTC
- Director Kreps Matthew was granted 1,114 shares, increasing direct ownership by 52% to 3,264 units (SEC Form 4)
- Director Winn Charles Arch was granted 1,331 shares, increasing direct ownership by 10% to 14,431 units (SEC Form 4)
- Director Halinski John William was granted 1,331 shares, increasing direct ownership by 11% to 13,542 units (SEC Form 4)
- Director Stober Eric was granted 1,473 shares, increasing direct ownership by 7% to 21,127 units (SEC Form 4)
- Director Mcfarland Robert N was granted 1,331 shares, increasing direct ownership by 6% to 22,292 units (SEC Form 4)
- Director Wilkinson Tom was granted 1,331 shares, increasing direct ownership by 4% to 32,254 units (SEC Form 4)
- SEC Form 10-K filed by Astrotech Corporation (DE)
- Astrotech Corporation (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Astrotech Reports Fiscal Year 2026 Financial Results
- Innventure Leadership Increases Focus on Accelsius Value Creation, Implements Significant Cost Cuts, and Strengthens Board Independence
Latest AVTR
- Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
- EVP and CFO Garner Todd W was granted 49,688 shares (SEC Form 4)
- SEC Form 3 filed by new insider Garner Todd W
- Avantor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Avantor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Avantor appoints new Chief Financial Officer
- UBS initiated coverage on Avantor with a new price target
- Amendment: Avantor Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- President and CEO Ligner Emmanuel covered exercise/tax liability with 29,803 shares, decreasing direct ownership by 4% to 737,334 units (SEC Form 4) to satisfy withholding obligation
- EVP, Chief HR Officer Hankamer Brittany covered exercise/tax liability with 181 shares, decreasing direct ownership by 0.07% to 248,864 units (SEC Form 4) (withholding tax)